Unknown

Dataset Information

0

Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia.


ABSTRACT: Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct characteristics and prognoses. Although cytogenetic changes and gene mutations are associated with AML prognosis, there is a need to identify further factors. CD56 is considered a prognostic factor for AML, which is abnormally expressed in leukemia cells. However, a clear consensus for this surface molecule is lacking, which has prompted us to investigate its prognostic significance. Bone marrow samples of de novo non-M3 AML were collected to detect CD56 expression using multiparameter flow cytometry (FCM). As a result, the CD56 expression in de novo non-M3 AML was found to be significantly higher than that in acute lymphoma leukemia (ALL, P = 0.017) and healthy controls (P = 0.02). The X-Tile program produced a CD56 cutoff point at a relative expression level of 24.62%. Based on this cutoff point, high CD56 expression was observed in 29.21% of de novo non-M3 AML patients. CD56-high patients had a poor overall survival (OS, P = 0.015) compared to CD56-low patients. Bone marrow transplantation (BMT) improved OS (P = 0.004), but a poor genetic risk was associated with an inferior OS (P = 0.002). Compared with CD56-low patients, CD56-high patients had lower peripheral blood platelet (PLT) counts (P = 0.010). Our research confirmed that high CD56 expression is associated with adverse clinical outcomes in de novo non-M3 AML patients, indicating that CD56 could be used as a prognostic marker for a more precise stratification of de novo non-M3 AML patients.

SUBMITTER: Sun Y 

PROVIDER: S-EPMC8049794 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5742276 | biostudies-literature
| S-EPMC2943753 | biostudies-literature
| S-EPMC6272103 | biostudies-literature
| S-EPMC5532631 | biostudies-other
| S-EPMC6483142 | biostudies-literature
| S-EPMC3767041 | biostudies-literature
| S-EPMC3512179 | biostudies-other
| S-EPMC6861270 | biostudies-literature
| S-EPMC7255376 | biostudies-literature
2022-11-23 | GSE201492 | GEO